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a b s t r a c t
Introduction: Extra-skeletal Ewing's sarcomas are very rare lesions to the spine surgeon, with
the intradural, extramedullary lesions being even rarer. Herein we present a patient with an
intradural, extramedullary form of Ewing's sarcoma and review the relevant literature. The
medical records, operative reports, radiographical studies and histological examinations of a
single patient are retrospectively reviewed.
Case report: A 31-year old male presented with back-pain, right-leg progressive paraparesis,
and inability to walk. Both motor and sensory disturbances were revealed on the right leg at
the clinical examination. Lumbar MRI showed two lesions. The ﬁrst one was an intradural,
extramedullary lesion at the L2-L3 level, while the second was smaller, located at the bottom
of the dural sac. The patient underwent gross total resection of the L2-L3 lesion after a
bilateral laminectomy. Histological examination was compatible with Ewing's sarcoma, and
was veriﬁed by molecular analysis. No other extra-skeletal or skeletal lesion was found. A
chemotherapy scheme was tailored to the patients' histological diagnosis. The patient
presented with local recurrence and bone metastasis 2 years after his initial diagnosis. A
second operation was performed and the follow up of the patient showed no disease
progression 18 months after revision surgery.
Conclusion: The spine surgeon should be aware of the existence of such rare entities, in order
to timely fulﬁll the staging process and institute the proper therapy. The management of
patients with extra-skeletal Ewing's sarcomas involves professionals as members of a
multidisciplinary team, all of which should co-operate for the patient's optimal outcome.
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Ewing's sarcomas are highly undifferentiated, primitive,
malignant, small round-cell neoplasms, arising usually in
children and young adults [1]. They are rare tumors that
account for 10% of all primary malignant bone tumors in
children and 3% of all childhood malignancies [2]. Moreover,
they are very aggressive lesions; approximately 25% of
patients have metastatic disease at the time of diagnosis [1].
Hereby we report an extremely rare case of an adult male with
primary intradural extramedullary Ewing's sarcoma (IEES) of
the spine and a skip lesion at the cul de sac of the dural sac, and
review the pertinent literature.
2. Case report
A 31-year old male with unremarkable medical history,
presented with back-pain, right leg progressive paresis (3/5
in all key muscle groups), causalgia and decreased sensation of
the same limb, consistent with cauda equina syndrome. His
lumbar spine magnetic resonance imaging (MRI) showed an
intradural, extramedullary space occupying lesion behind theFig. 1 – (a) Sagittal short tau inversion recovery MR image shows
from L1-L2 disc, along the L2 vertebral body up to L2-L3 disc. The 
skip lesion at the level of L5 vertebral body. (b) Sagittal T1 MR im
patchy, moderate enhancement from the mass. Note that the CS
signal in T1 sequence that enhances, indicative of high protein L2-L3 vertebral bodies, 5.2 mm  1.3 mm in size, occluding the
spinal canal and displacing the cauda equina to the left side
and posteriorly. A second smaller lesion was found behind the
L5 vertebral body with similar imaging characteristics. Both
lesions enhanced inhomogeneously after contrast adminis-
tration (Fig. 1a and b). The differential diagnosis included
neoplasms such as the ependymoma, meningioma, neur-
inoma and spinal metastasis. Imaging of the neuraxis and
thoraco-abdominal staging showed no evidence of other
pathologic lesions.
L1-L3 laminectomy was undertaken and a ﬂeshy mass was
revealed after opening the dura that intermingled with the
lumbar nerve roots. Gross total resection of the tumor was
achieved and the specimen was sent for histopathological
examination. No attempt was made to remove the second
lesion, since there were no neurologic deﬁcits and the surgical
decision was to wait for the histology of the resected mass.
Hematoxylin – Eosin stains highlighted neoplastic cells
with small, round or ovoid intensely stained nuclei and little
cytoplasm with clear demarcation. Immunohistochemistry
showed intense and diffuse positivity for CD-99, while did not
stain for GFAP, EMA, cytokeratin 8 and 18, AE1/AE3, S-100 and
neuroﬁlaments. Reverse transcriptase polymerase chain reac-
tion (RT-PCR) revealed the presence of the EWS/FLI1 fusion an intramedullary mass in the conus medullaris, extending
mass has a heterogeneous low signal and there is a second,
age after intravenous administration of gadolinium shows
F between the main and satellite lesion has abnormal high
content or blood.
Fig. 2 – (a and b) Postoperative MR images verify the gross total removal of the L2-L3 lesion. (c) 99Tc bone-scan 2 years after the
initial diagnosis. The increased technetium uptake (arrows) indicates new metastatic lesions. (d) A 2-year follow-up MRI
study shows local recurrence of the sarcoma at the L2-L3 level.
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immediate postoperative contrast-enhanced MRI showed no
remaining mass behind the L2-L3 level (Fig. 2a and b). There
was impressive relief of the symptomatology after surgery.
Subsequently, the patient was referred to the tumor board
meeting of our University Hospital for further management,
but was not fully compliant with the treatment protocol
proposed including radiotherapy and chemotherapy. His
treatment was complemented only with chemotherapy
(Vincristine, Doxorubicin, Cyclophosphamide-Mesna, Dacti-
nomycin, Ifosphamide-Mesna and Etoposide), which resulted
in complete remission of the residual tumor at the L5 level.
Imaging follow-up 3 months after surgery showed no evidence
of recurrence at any lumbar level, including L5.
The patient returned with right lower limb symptoms 2
years after the operation. MRI of the right hip and knee showed
osseous lesions with imaging features indicative of metastatic
deposits. A bone scintigram conﬁrmed increased radioisotope
uptake at the right hip and knee region due to distant
metastases (Fig. 2c). MRI of the lumbar spine showed local
recurrence of the intraspinal tumor at the L2-L3 level without
evidence of any other skip lesion (Fig. 2d). The patient
underwent revision surgery with subtotal removal of the
recurrent tumor due to ﬁrm ﬁbrous attachments of the lesion
with the adjacent dural walls. After the second operation the
patient was referred to oncologists for further treatment. Thepatient again received only chemotherapy and refused RT; the
patient reported no symptoms suggestive of disease progres-
sion 18 months after his second operation.
3. Discussion
A total of 27 cases with IEES have been described in the
literature (Table 1). This neoplasm is more common in males
[3–14] during the 4th decade of life [1,11,15,16] and usually
affects the thoracic and lumbar regions [3–7,9–13,15–20];
however, there are a few reports involving cervical spine
[14,21–23]. The symptomatology is similar with any other
space-occupying lesion of the spinal cord [3–18,20,22]. The MRI
usually reveals one or more inhomogeneous lesion, with solid
(isointense on T1, hyperintense on T2 and irregularly
enhancing after gadolinium administration) and cystic com-
ponents (hyperintense on T1, with numerous septations and
mural nodules) [3,11,15,18]. Systematic screening and screen-
ing of the neuraxis for synchronous lesions is justiﬁed
[3,5,8,9,13,17,22].
The simultaneous existence of two intradural tumors in our
patient at the L2-L3 level and the L5 level may be considered as
a very unusual presentation pattern. Based on the histological
conﬁrmation of the surgically removed lesion, it may be
suggested that the excised lesion was the primary tumor and
Table 1 – Review of reported cases with intradural, extramedullary Ewing's sarcomas.
Author (year) Sex/age Region Secondary
Ewing lesions
Treatment Follow-up Outcome Comments
Bouffet (1997) [3] M/9.5 T11-T12 L3-L5 Surgery, XRT, Chemo 4 m Death –
M/16 L2-L3 T4-T6, lungs,
brain
Surgery XRT, Chemo 5 m Death Extra-CNS metastasis
Weil (2001) [13] M/21 T10-T11 No STR, XRT, chemo 30 m Disease free Concomitant parietal
lobe leiomyoma
Rock (2002) [15] F/61 L4-L5 No GTR, XRT, Chemo,
spinal radiosurgery
5 y Stable Recurrence at 4 years,
L3 burst fracture
Uesaka (2003) [22] F/11 C7-T1 No STR NA NA –
Woestenborghs
(2005) [14]
M/11 C4-T2 No STR, Chemo NA NA –
Mobley (2006) [10] M/32 L2-L4 No GTR, XRT, Chemo 12 m Death Recurrence at 8 m
Haresh (2008) [5] M/26 T11-S2 T6-T7 GTR, XRT, Chemo 6 m Clinically stable –
Jia (2009) [6] M/28 T12-L3 No GTR 9 m Recurrence Misdiagnosed as
meningitis, Concomitant
hydrocephalus
Klimo (2009) [7] M/10 L4 No GTR, XRT, Chemo 12 m Disease free –
Kim (2009) [23] F/32 C3-C5 No STR, XRT, Chemo 12 m Disease free –
Muzzafar (2010) [11] M/38 L2-S2 No GTR, XRT, Chemo 2 m Stable Two nerve rootlets were
sacriﬁced, DVT
Vincentelli (2010) [16] F/40 T11-L4 No STR, XRT, Chemo 6 m Disease free Hemorrhagic lesion
Mateen (2011) [9] M/60 L2-L3 Whole CNS STR, XRT, Chemo 48 m Death Affected the whole CNS
M/50 T10-L1 No GTR, XRT, Chemo 26 m Disease free –
Karikari (2011) [18] F/56 L1 No GTR, XRT, Chemo NA Disease free –
Ellis (2011) [4] M/35 T12-L2 No STR 2 m NA –
Bazzocchi (2013) [17] F/44 L4-L5 Thorasic and
lumbar levels
GTR, XRT, Chemo 31 m Recurrence Breast cancer
Khalabatari (2013) [19] F/28 L5-S1 No GTR, XRT, Chemo 6 y Disease free Acute hemorrhage and
cauda equina syndrome
Pancucci (2013) [12] M/55 L4-S2 No GTR, XRT, Chemo 13 m Disease free Intratumoral bleeding
F/25 L2-L3 No GTR 14 m Recurrence History of degenerative
leukoencephalopathy
Lozupone (2014) [20] F/44 L1-S3 No GTR, XRT, Chemo 6 m Neurological
improvement
Multiple masses
Mardekian (2014) [8] M/26 T12/L1 No GTR NA NA –
M/70 T12-L1 No STR NA NA History of multiple
tumors
Zhao (2014) [24] M/14 L2-S1 No GTR, XRT, Chemo 12 m Clinically stable Mimicking a giant nerve
sheath tumor
Gong (2015) [21] F/39 C4-C6 No GTR, XRT, Chemo 3 y Recurrence and
metastasis in
cauda equina
–
Present case M/31 L2-L3 L5-S1 GTR of the L2-L3
lesion, Chemo
3.5 y Recurrence and
metastasis
IEES with skip lesion
M, male; F, female; CNS, central nervous system; GTR, gross total resection; STR, subtotal resection; XRT, external beam irradiation; Chemo,
chemotherapy; NA, not available; m, months; y, years; DVT, deep vein thrombosis.
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responded to chemotherapy. Skip intradural metastasis that
present simultaneously with the primary intradural lesion is
extremely uncommon for Ewing sarcomas with only two cases
reported in the literature [3,21].
IEES lesions are soft, friable and ﬂeshy, purple in color and
highly vascular [7–9,12,22]. It invades both the spinal cord and
nerve roots, without any clear dissection plane [7,9]. Histologi-
cally there are numerous small round blue cells arranged in
patternless sheets [3,6,9,11,18]. They express high levels of
the MIC-2 antigen when stained with the CD99 antibody
[3,6,11,18]. RT-PCR analysis depicts a EWS-FLI-1 fusion
transcript [22] and ﬂuorescence in situ hybridization analysis
highlights the chromosomal translocation t(11;22)(q24;q12)
[3,11,18].The treatment of IEES is multidisciplinary. Gross total
resection is usually the goal of surgery [5–12,15–18,22].
However, that is not always possible. Most of the patients
beneﬁt from 5–6 cycles of chemotherapy [3,5–7,9,10,12–
18,20,22,23] with vincristine, doxorubicin, cyclophosphamide
and consolidation with etoposide and ifosfamide. Irradiation
with 30–50 Gy at the tumor bed, delivered at approximately 25–
28 fractions improves treatment outcome [3,5,7,9–13,15–
18,22,23]. However, there is considerable disagreement regard-
ing the management of secondary lesions.
The literature is characterized by huge variations in the
duration of follow-up. Pain is relieved in most cases
immediately after surgery and there is variable improvement
in the neurological deﬁcits [8,24]. IEES have a high tendency for
local recurrences [6,10,12,15,17] and distal metastases [3,9,15]
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therapy and/or conformal radiation). Prognosis in terms of
morbidity and mortality is dismal despite the fact that recent
treatment advances have increased disease free survival and
extended life expectancy [6,7,9,12,13,15,16,19,24]. The compli-
ance of the patient is also important with respect to tumor
response; however, in our case the patient was reluctant to
proceed with RT with relative compromise of his survival.
Extraskeletal Ewing's sarcomas should be included in the
list of differential diagnosis of intradural extramedullary
spinal lesions. Immunohistochemistry and molecular analysis
set the diagnosis. Such patients should undergo neuraxis
screening and be controlled for intraspinal skip lesions, distant
metastatic deposits and disease recurrence. Therefore, a
multidisciplinary approach is necessary in order to optimize
the treatment planning and ﬁnal outcome of this subgroup of
patients.
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